SCHEMBL30134023

SCHEMBL30134023

CC(=O)c1ccc(CN2CCOC(C)(C)C2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.55
MAOB P27338 1/20 0.55
RCOR1 Q9UKL0 1/20 0.55
HRH3 Q9Y5N1 8/20 0.48
GRM2 Q14416 1/20 0.45
HPGD P15428 1/20 0.44
KMT2A Q03164 2/20 0.42
PIK3CD O00329 1/20 0.42
PIK3R2 O00459 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
PIK3CG P48736 1/20 0.42
PIK3R5 Q8WYR1 1/20 0.42
PIK3R3 Q92569 1/20 0.42
PDE1B Q01064 1/20 0.41
HIF1A Q16665 1/20 0.41
EPAS1 Q99814 1/20 0.41
HRH4 Q9H3N8 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11868 0.82 ALDH1A1 (0.49) HRH3GRM2KMT2APDE1BMAPK1
SCHEMBL1427580 0.81 KDM4E (0.46) HRH3GRM2PIK3CDPIK3R2PIK3CA
SCHEMBL540760 0.80 HRH3 (0.65) HRH3HPGDKMT2AHIF1AEPAS1
SCHEMBL2073777 0.80 SIGMAR1 (0.50) KMT2ALMNA
SCHEMBL30133993 0.79 DGKZ (0.40) KDM1AMAOBRCOR1HRH3GRM2
SCHEMBL12449608 0.78 KCNH2 (0.54) HRH3GRM2KMT2APDE1BHIF1A
SCHEMBL2556969 0.76 GRM2 (0.42) GRM2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL24733057 0.75 HRH3 (0.75) KDM1AMAOBRCOR1HRH3KMT2A
SCHEMBL31003196 0.74 KDM1A (0.55) KDM1AMAOBRCOR1HRH3KMT2A
SCHEMBL11005203 0.73 HRH3 (0.76) HRH3HPGDHRH4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119119033-A Pyrazolopyridone compounds 百济神州有限公司 2024-12-13 CN disclosed
US-20240300951-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-09-12 US disclosed
US-20240270751-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-08-15 US disclosed
EP-4380936-A1 PYRAZOLOPYRIDINONE COMPOUNDS BeiGene, Ltd. (KY) 2024-06-12 EP disclosed
CN-117836296-A Pyrazolopyridone compounds 百济神州有限公司 2024-04-05 CN disclosed
WO-2023011456-A1 PYRAZOLOPYRIDINONE COMPOUNDS BEIGENE, LTD. (KY) 2023-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300951-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK KDM1A 1558/4885MAOB 4197/4885RCOR1 3296/4885
US-20240270751-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK KDM1A 1558/4885MAOB 4197/4885RCOR1 3296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.